V. Husak et M. Myslivecek, SOME RADIATION PROTECTION PROBLEMS CONNECTED WITH THE USE OF RE-186-HEPD AND SM-153-EDTMP FOR PALLIATIVE THERAPY OF BONE METASTASES, Journal of radioanalytical and nuclear chemistry, 209(2), 1996, pp. 361-365
The paper deals with the problem of the outpatient administration of R
e-186-HEDP and Sm-153-EDTMP for palliative therapy of bone metastases.
The subsequent 6 hours stay of the treated patients in a department o
f nuclear medicine appears to be in compliance with regulations propos
ed in the Czech Republic as well as with ICRP recommendations.